Sign In

Graham Walmsley

Healthcare Investor

Dr. Graham Walmsley, MD PhD, is a Co-Founder and Managing Member at Logos Global Management, LP, a biotechnology-focused investment fund located in San Francisco. Logos implements a unique approach by integrating data analytics, scientific expertise, and clinical knowledge to pinpoint groundbreaking therapies within the healthcare sector.

With a stellar educational background, Dr. Walmsley earned his Doctor of Medicine (M.D.) from Stanford University School of Medicine, a Doctor of Philosophy (Ph.D.) in Stem Cell Biology & Regenerative Medicine from the same institution, and a Bachelor of Arts (B.A.) with highest honors in Molecular and Cell Biology from the University of California, Berkeley.

His professional journey includes roles such as Board Director at several notable companies like Olema Oncology, Akero Therapeutics, and ALX Oncology. Additionally, he has served as a Board Observer at Oyster Point Pharma, Inc., Aligos Therapeutics, and Turnstone Biologics. Dr. Walmsley's experience also extends to positions such as Head of Business Development at Jecure Therapeutics and Principal at Versant Ventures.

Moreover, he has been affiliated with prominent organizations like Stanford Hospital & Clinics as an Affiliated Trainee. His diverse background and rich experience underscore his versatile skill set in the biotechnology and investment sectors.

Highlights

Aug 27 · StreetInsider.com
Form N-PX VANGUARD SCOTTSDALE FUND For: Jun 30 - StreetInsider.com
Feb 24 · Yahoo Finance
Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs - Yahoo Finance
Graham Walmsley
Add to my network

Location

San Francisco, California, United States